Chromatographic separation of the ethyl acetate extract of roots of Polyalthia cerasoides has led to the isolation of the new compound, 6,8-dihydroxy-7-methoxy-1-methyl-azafluorenone. This compound exhibited potent cytotoxic activities with IC 50 values in the range of 2.64-3.58 μg.mL -1 for A549, GLC4 and GLC4/Adr cells, but was not recognized by ABCC1/MRP1 protein. The compound also showed very strong inhibition of M. tuberculosis using a broth microdilution method, with an MIC value of 0.78 μg.mL -1 , which was equal to that of ofloxacin, one of the four antibiotic drugs used as a positive control.
Polyalthia cerasoides (Roxb.) Bedd. (Annonaceae) is a medium-sized tree up to 5-15 meters tall, occurring mainly in Asiatic and Oceanic areas such as Burma (Myanmar), South China, India, Indochina, Thailand, and Laos (Khammouan) [1a,1b] . Previous phytochemical studies of various parts of P. cerasoides have resulted in the characterization of a benzofuran derivative [2a] , oxoprotoberberine alkaloids [2b], dimeric aporphine alkaloids, a sesquiterpene, an isoquinoline alkaloid and triynoic acid [2c], and phytosterols [2d] . The constituents of Polyalthia species have shown remarkable antibacterial [2e], antifungal [3a] , cytotoxic [3b], and antimalarial [2e] properties. In traditional Thai medicine, P. cerasoides is used for the treatment of tuberculosis. Based on already known preliminary data from bioassay-guided fractionation, we undertook further cytotoxicity studies of the crude n-hexane, ethyl acetate, acetone and methanol extracts. We present here the results obtained from testing the ethyl acetate extract for cytotoxic activity. From this extract, a new azafluorenone was isolated and examined for its antimycobacterial activity. The new azafluorenone was isolated as yellow needle crystals from ethanol (mp 200.9-202.7ºC ). In the ESIMS, the molecular weight was indicated by the HRAPCIMS peak at m/z 257 [M + ], in combination with the measurement of the [M+H] + ion at m/z 258.0764 (cald. 258.0761 for C 14 H 12 NO 4 ). The presence of a hydroxyl group was suggested in the mass spectrum by a fragment ion base peak at m/z 239 (100) due to the direct loss of an 18 a.m.u. water unit from the C 14 H 12 NO 4 + ion. In addition, the fragment ions at m/z 242 (M + -Me) and 224 (M + -Me-H 2 O) in the mass spectrum indicated the presence of an OMe group in the position next to the OH group. As a unique group of alkaloids, azafluorenones NPC Natural Product Communications 2010 Vol. 5 No. 12 1931 -1934 show a characteristic UV spectrum; the substituted onychines (1-methyl-4-azafluorenone) give two absorption bands in the UV spectrum (MeOH); band I at 207 nm (2.35) and band II at 269 nm (2.48) that exhibit π→π* of an aromatic unit together with a double bond, and n→π* from a conjugated carbonyl chromosphore. In the IR spectrum, absorption bands attributable to hydroxyl (3526 cm -1 and 3329 cm -1 ) and the carbonyl of an unsaturated ketone (1701 cm -1 ) were observed. In addition, a C-O stretching vibration occurs at 1350 cm -1 indicating an ether moiety.
The 1 H NMR spectrum displayed only three unique signals: three aromatic [δ H 6.80, d, J = 5.53 Hz; 6.87, s, and 8.16, d, J = 5.53 Hz)], one methoxy resonance (δ H 4.13, s) and one C-methyl signal (δ H 2.56, s). All the direct proton-carbon connectivities were assigned following HMQC analysis. Using COSY, 1 H-1 H coupling constants and HMBC correlations, a trisubstitued pyridine moiety was readily established. HMBC correlations from protons of the methyl group at δ H 2.56 (1-Me) to three carbons of the pyridine unit [δ C 147.41(C-1), 129.72 (C-9a), and 124.16 (C-2)] indicated its para-position relative to the pyridine ring system. An additional weak HMBC correlation from this methyl group to a carbon at δ C 191.58 (C-9) suggested that the carbonyl functionality was attached ortho to the methyl moiety. Moreover, three carbon signals of the pyridine ring at δ C 166.35 (C-4a), 147.41 (C-1) and 124.1(C-2) were HMBC correlated with the proton signals at δ H 8.16 (H-3), 6.87 (H-5) and 8.16 (H-2). The one aromatic proton at δ H 6.87 (s) exhibited HMBC correlations to three quaternary carbons [δ C 151.89 (C-6), 139.13 (C-7), and 119.75 (C-8a)], three of which emerged to be connected to an oxygen heteroatom on account of their 13 C chemical shifts. The HMBC spectrum of this compound, which provided reciprocity from δ H 4.13 (7-OMe) to the carbon at δ C 139.13, clearly showed that the methoxy group was located on an aromatic ring. An additional strong HMBC correlation from proton δ H 6.87 (5-H) to a carbon at δ C 139.13 suggested that a methoxy group was located at the C-7 position. Moreover, a series of NOE experiments were carried out in order to assign the methoxy group at position 7. Enhancements were observed in the pyridine ring, but not in the phenolic ring ( Figure 1 ). Based on the above data, the compound was identified as 6,8-dihydroxy-7-methoxy-1-methyl-azafluorenone, an onychine analogue not previously reported.
The inhibition effects of P. cerasoides root extracts were investigated using the MTT assay. The IC 50 value was determined against three human lung cancer cell lines. Of the four extracts, the ethyl acetate one exhibited the highest antiproliferative activity with IC 50 values of 2.7, 4.3 and 3.4 μg.mL -1 for A549, GLC4 and GLC4/Adr cells, respectively (Table 2) . Strong growth inhibitory activity was also found for the n-hexane and acetone extracts with IC 50 values in the range from 3.5 to 11.4 μg.mL -1 ; the methanol extract was only weakly active. The ethyl acetate extract was, therefore, considered for subsequently purification and the new active compound, 6,8-dihydroxy-7-methoxy-1-methylazafluorenone, was isolated. This compound showed inhibitory activity against the three cancer cell lines equal to or higher than that of the ethyl acetate extract. The IC 50 values of the crude extracts and the pure compound showed similar values against both GLC4 and GLC4/Adr cells. It is proposed that neither the crude extracts nor the pure compound are recognized by ABCC1/MRP1 protein.
The new compound was also examined for its efficacy against M. tuberculosis using a broth microdilution method. It demonstrated very strong inhibition, with a MIC value of 0.78 μg/mL, equal to that of ofloxacin, one of four antibiotic drugs used as positive controls. This antimycobacterial activity is consistent with a previous report for compounds isolated from P. cerasoides roots [2c]. Three compounds isolated from seeds exhibited antiproliferative action against the CACO-2 cell line, and two phytosterols showed antimutagenic activity [2d] . It has been reported that some extracts of this plant have antimalarial [2c] and antioxidant potential [4a] .
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Extraction and isolation:
Air-dried powdered roots (5 kg) were successively defatted with n-hexane, WP0455 (18 L x 3 days x 7 times) and then sequentially extracted at room temperature with ethyl acetate, WP0456 (18 L x 3 days x 7 times), acetone, WP0457 (18 L x 3 days x 6 times), and methanol, WP0458 (18 L x 3 days x 6 times), followed by filtration. The filtrates were combined and evaporated to dryness under reduced pressure to afford 14.1, 45.6, 144.0 and 359.5 g of residues, respectively. Based on the bioassay results (carried out by our collaborators from Chiang Mai University of Thailand), the ethyl acetate extract was chosen for further study. This (45.6 g) was subjected to a coarse separation by silica gel CC (400 g), eluting with various proportions of ethyl acetate _ n-hexane, followed by an increasing amount of methanol in ethyl acetate, and finally with methanol. Fractions (1000 mL each) were collected and combined on the basis of TLC behavior. The solvents were evaporated to dryness to afford 7 fractions (F 1 -F 7 ). Fraction F 3 (2.27 g), eluted by 10% ethyl acetate-n-hexane, was obtained as a semisolid. Further separation was achieved by CC over silica gel (100 g), eluting with n-hexane, followed by an increasing amount of methanol in ethyl acetate, and finally with methanol. Fractions were collected and combined before the solvents were removed under reducing pressure to afford subfractions A 1 -A 2 . Subfraction A 2 (0.87 g), was separated by CC over silica gel to yield a yellow solid subfraction B 2 (0.38 g). This was recrystallized from ethanol to give purified yellow needles (0.38 g) of azafluorenone. 
Cell lines and culture conditions:
The crude extracts and the pure compound were tested on 3 cancer cell lines {non small cell lung cancer (A549), adriamycinsensitive small cell lung cancer (GLC4), and adriamycin-resistant small cell lung cancer (GLC4/Adr) expressing ABCC1/MRP1 [4b,4c]}. All were cultivated in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin in a 37ºC incubator under 5% CO 2 .
Anti-proliferation assay:
The cellular viability of cell A549 was determined using the sulforhodamine B (SRB) method. The sulforhodamine B assay is used for cell density determination, based on the measurement of cellular protein content. The cellular viability of cell lines GLC4 and GLC4/Adr were determined by using the conventional MTT-colorimetric method. Cells were incubated under cell culture conditions with various concentrations of pure compound up to 62.5 μg.mL -1 and crude extracts up to 250 μg.mL -1 for 72 h; the cells without either crude extracts or pure compound served as a blank. At 72 h, 50 µL of MTT (2.5 mg.mL -1 ) was added to each well. The culture plates were gently shaken and incubated for 4 h. MTT in solution was converted to blue formazan crystals by mitochondrial succinate dehydrogenase of the living cells. The formazan crystals formed within the cells were solubilized with 50 µL DMSO and shaken well. The obtical density (OD) of the blue formazan chromophore was determined at 550 nm in an automated plate reader [4d]. The cytotoxic parameter was expressed as the concentration of compound in which the cellular proliferation was inhibited by 50% (%IC 50 ). The percentage of cell-growth inhibition (%IC) was calculated using the formula:
x 100
1934 Natural Product Communications Vol. ) and 30 μg.mL -1 kanamycin. The mixture was then incubated at 37 o C in a 200 rpm shaker incubator until the optical density (OD) at 550 nm was between 0.5 and 1. For batch cultivation, the starter cultures were transferred at the rate of 1/10 volume to the 7H9 broth and incubated at 37 o C in a 200 rpm shaker incubator until the OD550 nm was approximately 0.5 to 1. The cells were pelleted, washed and suspended in PBS buffer, and then sonicated 8 times for 15 secs each. The sonicated samples were then aliquoted and frozen at -80°C for up to 2 to 3 months prior to use. Titer stocks were determined by the colony forming unit (cfu) assay and the seeding density for anti-TB assay was optimized by serial dilutions. The dilution that grew at logarithmic phase on day 7 was used as an optimal bacterial seeding density. For assay in a 384-well format, the seeding was approximately 2x10 4 to 1x10 5 cfu/mL/well. The assay was performed in duplicate, each well containing 5 μL of test sample serially diluted in 5% dimethyl sulfoxide, followed by 45 μL of cell suspension prepared as described above.
Plates were incubated at 37°C for 7 days and the fluorescence signals were measured using a SpectraMax M5 microplate reader (Molecular Devices, USA) in the bottom-reading mode at the excitation and emission wavelengths of 485 nm and 535 nm. Fluorescence signals on day zero were used as background, which was used to subtract the signals on day 7. The percentage growth inhibition was calculated from the mean of the fluorescence unit of cells treated with sample (FUT) and untreated cells (FUC), according to the following equation:
The lowest drug concentration that inhibits cell growth by 90% is reported as the Minimum Inhibitory Concentration (MIC). Rifampicin, streptomycin, isoniazid and ofloxacin were used as positive controls, and 0.5% DMSO as a negative control.
